Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Rachel Campbell, Madeleine T King, Martin R Stockler, Yeh Chen Lee, Felicia T Roncolato & Michael L Friedlander. (2023) Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice. Patient Related Outcome Measures 14, pages 111-126.
Read now
Read now
Rebecca Mercieca-Bebber, Madeleine T King, Melanie J Calvert, Martin R Stockler & Michael Friedlander. (2018) The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Related Outcome Measures 9, pages 353-367.
Read now
Read now
Are Kristensen, Tora S. Solheim, Tore Amundsen, Harald H. Hjelde, Stein Kaasa, Sveinung Sørhaug & Bjørn H. Grønberg. (2017) Measurement of health-related quality of life during chemotherapy – the importance of timing. Acta Oncologica 56:5, pages 737-745.
Read now
Read now
Laura Dormer. (2011) Quality of life in cancer clinical trials: researchers, patients and policy makers. Expert Review of Pharmacoeconomics & Outcomes Research 11:6, pages 661-665.
Read now
Read now
Articles from other publishers (72)
Sieta T. de Vries, Noral Huda S. Al-Mugoter, Irena Petkoska, Stefan Verweij, André J. A. Elferink & Peter G. M. Mol. (2023) Comment on: “The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022”. Applied Health Economics and Health Policy.
Crossref
Crossref
Gayathri Vijayakumar & Alan T. Blank. (2023) Patient‐reported outcome tools in musculoskeletal oncology. Journal of Surgical Oncology 128:3, pages 418-424.
Crossref
Crossref
Dominique V.C. de Jel, Danny A. Young-Afat, Marleen M. Ooms-Renckens, Ludi E. Smeele, Hinne A. Rakhorst, J.J. Hendrickx, F.J.P. Hoebers, C.M. Speksnijder, M.J.H. Witjes, H. Ghaeminia, M. Lacko, R.J. Baatenburg de Jong, R.P. Takes, R.J.J. van Es, H.P. Verschuur, J.C. Jansen, O. Hamming Vrieze, A.J.M. van Bemmel & L.Q. Schwandt. (2023) Patients’ and Healthcare Professionals’ Perspectives on Better Use of Patient-Reported Outcome Measures in Head and Neck Cancer. Value in Health 26:8, pages 1210-1216.
Crossref
Crossref
Robert J. Motzer, Pratik P. Rane, Todd L. Saretsky, Deepshikha Pawar, Allison Martin Nguyen, Murali Sundaram, Joseph Burgents, Rishabh Pandey & Katja Rudell. (2023) Patient-reported Outcome Measurement and Reporting for Patients with Advanced Renal Cell Carcinoma: A Systematic Literature Review. European Urology.
Crossref
Crossref
Emma J.M. Grigor, Brendon Bitoiu, Camille Zeitouni & Jing Zhang. (2023) Patient-reported outcomes following free flap lower extremity reconstruction: A systematic review and meta-analysis. Journal of Plastic, Reconstructive & Aesthetic Surgery 76, pages 251-267.
Crossref
Crossref
Dominik Menges, Henock G. Yebyo, Sergio Sivec-Muniz, Sarah R. Haile, Michaela C. Barbier, Yuki Tomonaga, Matthias Schwenkglenks & Milo A. Puhan. (2022) Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment. European Urology Oncology 5:6, pages 605-616.
Crossref
Crossref
Marwan Alrasheed, Jeff Jianfei Guo, Alex C. Lin, Patricia R. Wigle, Angelica Hardee & Ana L. Hincapie. (2022) Association between polypharmacy, patient-reported symptoms, and quality of life among nonalcoholic fatty liver disease patients in the United States. Drugs & Therapy Perspectives 38:11, pages 490-498.
Crossref
Crossref
Michael D Brundage, Norah L Crossnohere, Jennifer O’Donnell, Samantha Cruz Rivera, Roger Wilson, Albert W Wu, David Moher, Derek Kyte, Bryce B Reeve, Alexandra Gilbert, Ronald C Chen, Melanie J Calvert & Claire Snyder. (2022) Listening to the Patient Voice Adds Value to Cancer Clinical Trials. JNCI: Journal of the National Cancer Institute 114:10, pages 1323-1332.
Crossref
Crossref
Carlos H. Barrios, Shigehira Saji, Nadia Harbeck, Hong Zhang, Kyung H. Jung, Sheetal Patel, Shilpen Patel, Anh Nguyen Duc, Mario Liste-Hermoso, Stephen Y. Chui & Elizabeth A. Mittendorf. (2022) Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer. npj Breast Cancer 8:1.
Crossref
Crossref
Ameeta Retzer, Stephanie Sivell, Hannah Scott, Annmarie Nelson, Helen Bulbeck, Kathy Seddon, Robin Grant, Richard Adams, Colin Watts, Olalekan Lee Aiyegbusi, Pamela Kearns, Samantha Cruz Rivera, Linda Dirven, Elin Baddeley, Melanie Calvert & Anthony Byrne. (2022) Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra study. BMJ Open 12:9, pages e057712.
Crossref
Crossref
Claire Snyder, Norah Crossnohere, Madeleine King, Bryce B Reeve, Andrew Bottomley, Melanie Calvert, Elissa Thorner, Albert W Wu & Michael Brundage. (2022) The PROTEUS-Trials Consortium: Optimizing the use of patient-reported outcomes in clinical trials. Clinical Trials 19:3, pages 277-284.
Crossref
Crossref
Henry T. Blake, Jonathan D. Buckley, Brad J. Stenner, Edward J. O’Connor, Shane A. Burgess & Alyson J. Crozier. (2022) Sport Participation and Subjective Outcomes of Health in Middle-Aged Men: A Scoping Review. American Journal of Men's Health 16:2, pages 155798832210844.
Crossref
Crossref
Rachel Campbell, Madeleine T. King, Yeh Chen Lee, Linda Mileshkin, Margaret-Ann Tait & Claudia Rutherford. 2022. Advances in Diagnosis and Management of Ovarian Cancer. Advances in Diagnosis and Management of Ovarian Cancer
225
241
.
Michael D. Brundage & Claire F. Snyder. 2022. Handbook of Quality of Life in Cancer. Handbook of Quality of Life in Cancer
163
187
.
Joslyn S. Kirby. (2022) Patient-Reported Outcomes in Dermatology. JAMA Dermatology 158:1, pages 97.
Crossref
Crossref
Sofía Elizabeth Muñoz, Ricardo Sánchez & Ligia Elena Del Toro. (2021) Evaluación de las características operativas de la versión 2.2018 del instrumento de evaluación del malestar emocional de la National Comprehensive Cancer Network en pacientes atendidos en el Instituto Nacional de Cancerología, Bogotá. Biomédica 41:4, pages 721-733.
Crossref
Crossref
Miss Charlotte L. Moss, Ajay Aggarwal, Asad Qureshi, Benjamin Taylor, Teresa Guerrero-Urbano & Mieke Van Hemelrijck. (2021) An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice. Health and Quality of Life Outcomes 19:1.
Crossref
Crossref
Claire Snyder, Alexandra Gilbert, David Moher, Derek Kyte, Ellie Daniels, Madeleine King, Melanie Calvert, Ronald C Chen & Michael Brundage. (2021) Recommendations for including or reviewing patient reported outcome endpoints in grant applications. BMJ, pages n1367.
Crossref
Crossref
Rani Kumari, Rachna Gupta, Manjeet Singh Bhatia & Suresh Kumar Gupta. (2021) Assessment of adverse drug reactions of psychopharmacological drugs in patients of psychiatric disorders. Journal of Pharmacovigilance and Drug Research 2:2, pages 27-32.
Crossref
Crossref
Stephen W. W. Chan, C. W. Chien, Arnold Y. L. Wong & Marco Y. C. Pang. (2021) Translation and psychometric validation of the traditional Chinese version of patient-reported outcomes measurement information system Pediatric-25 Profile version 2.0 (PROMIS-25) in Chinese Children with Cancer in Hong Kong. Quality of Life Research 30:6, pages 1779-1791.
Crossref
Crossref
Hui‐Yao Huang, Hong Wang, Ju‐Fang Shi, Ya‐Na Bai, Le Wang, Cheng‐Cheng Liu, Xin‐Xin Yan, Guo‐Xiang Liu, Xian‐Zhen Liao, Dian Shi, A‐Yan Mao, Jian‐Song Ren, Xiao‐Jie Sun, Hai‐Jing Guan, Wei‐Dong Huang, Hai‐Ke Lei, Ji‐Yong Gong, Yun‐Yong Liu, Lin Zhu, Bing‐Bing Song, Lin‐Bing Du, Lan‐Wei Guo, Yu‐Qin Liu, Ying Ren, Li Lan, Jin‐Yi Zhou, Xiao Qi, Xiao‐Hua Sun, Pei‐An Lou, Shou‐Ling Wu, Yu Tang, Ni Li, Kai Zhang, Ning Li, Wan‐Qing Chen, Min Dai & Jie He. (2020) Health‐related quality of life of patients with colorectal neoplasms in China: A multicenter cross‐sectional survey. Journal of Gastroenterology and Hepatology 36:5, pages 1197-1207.
Crossref
Crossref
Jatin Shah, Sharon Shacham, Michael Kauffman, Patrick Daniele, Dimitrios Tomaras, Gabriel Tremblay, Rene-Olivier Casasnovas, Marie Maerevoet, Josee Zijlstra, George Follows, Joost S. P Vermaat, Nagesh Kalakonda, Andre Henri Goy, Sylvain Choquet, Eric Van Den Neste, Brian T Hill, Catherine Thieblemont, Federica Cavallo, Fátima de la Cruz, John Kuruvilla, Nada Hamad, Reda Bouabdallah, Ulrich Jäger, Paolo Caimi, Ronit Gurion, Krzysztof Warzocha, Sameer Bakhshi, Juan Manuel Sancho, Michael Schuster, Miklós Egyed, Fritz Offner, Theodoros P Vasilakopoulos, Priyanka Samal, Agnes Nagy, Matthew Ku & Miguel Ángel Canales Albendea. (2021) Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma. Future Oncology 17:11, pages 1295-1310.
Crossref
Crossref
John H. StewartIVIV, Dan G. BlazerIIIIII, Maria Jose Godoy Calderon, Taylor M. Carter, Austin Eckhoff, Mohammad A. Al Efishat, Deemantha G. Fernando, Jason M. Foster, Andrea Hayes-Jordan, Fabian M. Johnston, Timothy B. Lautz, Edward A. Levine, Ugwuji N. Maduekwe, Christopher W. Mangieri, Omeed Moaven, Harveshp Mogal, Perry Shen & Konstantinos I. Votanopoulos. (2021) The Evolving Management of Peritoneal Surface Malignancies. Current Problems in Surgery 58:4, pages 100860.
Crossref
Crossref
Norah L. Crossnohere, Michael Brundage, Melanie J. Calvert, Madeleine King, Bryce B. Reeve, Elissa Thorner, Albert W. Wu & Claire Snyder. (2020) International guidance on the selection of patient-reported outcome measures in clinical trials: a review. Quality of Life Research 30:1, pages 21-40.
Crossref
Crossref
John M. Salsman, Suzanne C. Danhauer, Justin B. Moore, Mollie R. Canzona, David E. Victorson, Bradley J. Zebrack & Bryce B. Reeve. (2020) Optimizing the measurement of health‐related quality of life in adolescents and young adults with cancer. Cancer 126:22, pages 4818-4824.
Crossref
Crossref
Ramy R. Saleh, Nicholas Meti, Domen Ribnikar, Hadar Goldvaser, Alberto Ocana, Arnoud J. Templeton, Bostjan Seruga & Eitan Amir. (2020) Associations between safety, tolerability, and toxicity and the reporting of health‐related quality of life in phase III randomized trials in common solid tumors. Cancer Medicine 9:21, pages 7888-7895.
Crossref
Crossref
Michael D. Brundage, Albert W. Wu, Yonaira M. Rivera & Claire Snyder. (2020) Promoting effective use of patient-reported outcomes in clinical practice: themes from a “Methods Tool kit” paper series. Journal of Clinical Epidemiology 122, pages 153-159.
Crossref
Crossref
Diane St Germain, Andrea Denicoff, Andrea Torres, Joseph Kelaghan, Worta McCaskill‐Stevens, Grace Mishkin, Ann O’Mara & Lori M. Minasian. (2020) Reporting of health‐related quality of life endpoints in National Cancer Institute–supported cancer treatment trials. Cancer 126:11, pages 2687-2693.
Crossref
Crossref
Meghan Reading Turchioe, Lisa V Grossman, Annie C Myers, Dawon Baik, Parag Goyal & Ruth M Masterson Creber. (2020) Visual analogies, not graphs, increase patients' comprehension of changes in their health status. Journal of the American Medical Informatics Association 27:5, pages 677-689.
Crossref
Crossref
Omeed Moaven, Konstantinos I. Votanopoulos, Perry Shen, Paul Mansfield, David L. Bartlett, Greg Russell, Richard McQuellon, John H. Stewart & Edward A. Levine. (2019) Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin. Annals of Surgical Oncology 27:3, pages 772-780.
Crossref
Crossref
Bonnie Addario, Jan Geissler, Marcia K. Horn, Linda U. Krebs, Deborah Maskens, Kathy Oliver, Ananda Plate, Erin Schwartz & Nicole Willmarth. (2019) Including the patient voice in the development and implementation of patient‐reported outcomes in cancer clinical trials. Health Expectations 23:1, pages 41-51.
Crossref
Crossref
Stéphane Faury & Jérôme Foucaud. (2020) Health-related quality of life in cancer patients treated with immune checkpoint inhibitors: A systematic review on reporting of methods in randomized controlled trials. PLOS ONE 15:1, pages e0227344.
Crossref
Crossref
Samantha Cruz Rivera, Derek G. Kyte, Olalekan Lee Aiyegbusi, Anita L. Slade, Christel McMullan & Melanie J. Calvert. (2019) The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis. Health and Quality of Life Outcomes 17:1.
Crossref
Crossref
Jane Nixon, Sarah Brown, Isabelle L Smith, Elizabeth McGinnis, Armando Vargas-Palacios, E Andrea Nelson, Julia Brown, Susanne Coleman, Howard Collier, Catherine Fernandez, Rachael Gilberts, Valerie Henderson, Christopher McCabe, Delia Muir, Claudia Rutherford, Nikki Stubbs, Benjamin Thorpe, Klemens Wallner, Kay Walker, Lyn Wilson & Claire Hulme. (2019) Comparing alternating pressure mattresses and high-specification foam mattresses to prevent pressure ulcers in high-risk patients: the PRESSURE 2 RCT. Health Technology Assessment 23:52, pages 1-176.
Crossref
Crossref
Aishwarya ShuklaFang-Chi HsuBronwyn SlobogeanShannon LangmeadYao LuJaishri O. BlakeleyRoy E. Strowd. (2019) Association between patient-reported outcomes and objective disease indices in people with NF2. Neurology Clinical Practice 9:4, pages 322-329.
Crossref
Crossref
Claudia Rutherford, Rachel Campbell, Julia M. Brown, Isabelle Smith, Daniel S. J. Costa, Elizabeth McGinnis, Lyn Wilson, Rachael Gilberts, Sarah Brown, Susanne Coleman, Howard Collier & Jane E. Nixon. (2019) Comparison of generic and disease‐specific measures in their ability to detect differences in pressure ulcer clinical groups. Wound Repair and Regeneration 27:4, pages 396-405.
Crossref
Crossref
Claire Snyder, Michael Brundage, Yonaira M. Rivera & Albert W. Wu. (2019) A PRO-cision Medicine Methods Toolkit to Address the Challenges of Personalizing Cancer Care Using Patient-Reported Outcomes. Medical Care 57:Suppl 1, pages S1-S7.
Crossref
Crossref
Nathan I Cherny, Josep Tabernero & Elisabeth G E de Vries. (2019) ESMO-MCBS: setting the record straight. The Lancet Oncology 20:4, pages e192.
Crossref
Crossref
Elliott Tolbert, Michael Brundage, Elissa Bantug, Amanda L. Blackford, Katherine Smith & Claire Snyder. (2018) In proportion: approaches for displaying patient-reported outcome research study results as percentages responding to treatment. Quality of Life Research 28:3, pages 609-620.
Crossref
Crossref
Claudia Rutherford, Madeleine T. King, Phyllis Butow, France Legare, Anne Lyddiatt, Intissar Souli, Orlando Rincones & Dawn Stacey. (2018) Is quality of life a suitable measure of patient decision aid effectiveness? Sub-analysis of a Cochrane systematic review. Quality of Life Research 28:3, pages 593-607.
Crossref
Crossref
M. D. Brundage, L. Barbera, F. McCallum & D. M. Howell. (2018) A pilot evaluation of the expanded prostate cancer index composite for clinical practice (EPIC-CP) tool in Ontario. Quality of Life Research 28:3, pages 771-782.
Crossref
Crossref
Claire Snyder, Katherine Smith, Bernhard Holzner, Yonaira M. Rivera, Elissa Bantug & Michael Brundage. (2018) Making a picture worth a thousand numbers: recommendations for graphically displaying patient-reported outcomes data. Quality of Life Research 28:2, pages 345-356.
Crossref
Crossref
Lisa Barbera, Faith Lee & Rinku Sutradhar. (2019) Use of patient-reported outcomes in regional cancer centres over time: a retrospective study. CMAJ Open 7:1, pages E101-E108.
Crossref
Crossref
Mondher Toumi, Szymon Jarosławski, Christos Chouhaid, Bruno Fallissard & P. Auquier. 2019. Regulatory and Economic Aspects in Oncology. Regulatory and Economic Aspects in Oncology
57
65
.
Claudia Rutherford, Julia M. Brown, Isabelle Smith, Elizabeth McGinnis, Lyn Wilson, Rachael Gilberts, Sarah Brown, Susanne Coleman, Howard Collier & Jane Nixon. (2018) A patient-reported pressure ulcer health-related quality of life instrument for use in prevention trials (PU-QOL-P): psychometric evaluation. Health and Quality of Life Outcomes 16:1.
Crossref
Crossref
Elliott TolbertMichael BrundageElissa BantugAmanda L. BlackfordKatherine SmithClaire Snyder. (2018) Picture This: Presenting Longitudinal Patient-Reported Outcome Research Study Results to Patients. Medical Decision Making 38:8, pages 994-1005.
Crossref
Crossref
Divine E. Ediebah, Chantal Quinten, Corneel Coens, Jolie Ringash, Janet Dancey, Efstathios Zikos, Carolyn Gotay, Michael Brundage, Dongsheng Tu, Hans‐Henning Flechtner, Eva Greimel, Bryce B. Reeve, Martin Taphoorn, Jaap Reijneveld, Linda Dirven & Andrew Bottomley. (2018) Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials. Cancer 124:16, pages 3409-3416.
Crossref
Crossref
Rebecca Mercieca-Bebber, Melanie Calvert, Derek Kyte, Martin Stockler & Madeleine T. King. (2018) The administration of patient-reported outcome questionnaires in cancer trials: Interviews with trial coordinators regarding their roles, experiences, challenges and training. Contemporary Clinical Trials Communications 9, pages 23-32.
Crossref
Crossref
Michael J Palmer, Rebecca Mercieca-Bebber, Madeleine King, Melanie Calvert, Harriet Richardson & Michael Brundage. (2017) A systematic review and development of a classification framework for factors associated with missing patient-reported outcome data. Clinical Trials: Journal of the Society for Clinical Trials 15:1, pages 95-106.
Crossref
Crossref
Ameeta Retzer, Thomas Keeley, Khaled Ahmed, Jo Armes, Julia M Brown, Lynn Calman, Chris Copland, Fabio Efficace, Anna Gavin, Adam Glaser, Diana M Greenfield, Anne Lanceley, Rachel M Taylor, Galina Velikova, Michael Brundage, Rebecca Mercieca-Bebber, Madeleine T King, Melanie Calvert & Derek Kyte. (2018) Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol. BMJ Open 8:2, pages e017282.
Crossref
Crossref
Alice P. Chen, Sandra A. Mitchell, Lori M. Minasian & Diane C. St. Germain. 2018. Novel Designs of Early Phase Trials for Cancer Therapeutics. Novel Designs of Early Phase Trials for Cancer Therapeutics
193
208
.
Michael Brundage, Amanda Blackford, Elliott Tolbert, Katherine Smith, Elissa Bantug & Claire Snyder. (2017) Presenting comparative study PRO results to clinicians and researchers: beyond the eye of the beholder. Quality of Life Research 27:1, pages 75-90.
Crossref
Crossref
Claudia Rutherford, Rebecca Mercieca-Bebber & Madeleine King. 2018. The MASCC Textbook of Cancer Supportive Care and Survivorship. The MASCC Textbook of Cancer Supportive Care and Survivorship
109
125
.
Rebecca Mercieca-Bebber, Michael Friedlander, Melanie Calvert, Martin Stockler, Derek Kyte, Peey-Sei Kok & Madeleine T. King. (2017) A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: implications for generalisability and clinical practice. Journal of Patient-Reported Outcomes 1:1.
Crossref
Crossref
Jacek Rutkowski, Magdalena Szymanik, Maciej Blok, Joanna Kozaka & Renata Zaucha. (2017) Prospective evaluation of anxiety, depression and quality of life in medically inoperable early stage non-small cell lung cancer patients treated with stereotactic ablative radiotherapy. Reports of Practical Oncology & Radiotherapy 22:3, pages 217-222.
Crossref
Crossref
Sandra Nolte, Sicco H. van der Mei, Kerstin Strehl-Schwarz, Johanna Köster, Armin Bender, Matthias Rose, Johannes Kruse & Eva M. J. Peters. (2016) Comparison of patient-reported need of psycho-oncologic support and the doctor's perspective: how do they relate to disease severity in melanoma patients?. Psycho-Oncology 25:11, pages 1271-1277.
Crossref
Crossref
M. Friedlander, R.L. Mercieca-Bebber & M.T. King. (2016) Patient-reported outcomes (PRO) in ovarian cancer clinical trials—lost opportunities and lessons learned. Annals of Oncology 27, pages i66-i71.
Crossref
Crossref
Elissa T. Bantug, Theresa Coles, Katherine C. Smith, Claire F. Snyder, Julie Rouette & Michael D. Brundage. (2016) Graphical displays of patient-reported outcomes (PRO) for use in clinical practice: What makes a pro picture worth a thousand words?. Patient Education and Counseling 99:4, pages 483-490.
Crossref
Crossref
Lori Brotto, Michael Brundage, Paul Hoskins, Ignace Vergote, Andres Cervantes, Herraez A. Casado, A. Poveda, Elizabeth Eisenhauer & Dongsheng Tu. (2015) Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life. Supportive Care in Cancer 24:3, pages 1241-1249.
Crossref
Crossref
Simone A. van Dulmen, Sue Lukersmith, Josephine Muxlow, Elaine Santa Mina, Maria W.G. Nijhuis-van der Sanden & Philip J. van der Wees. (2015) Supporting a person-centred approach in clinical guidelines. A position paper of the Allied Health Community - Guidelines International Network (G-I-N). Health Expectations 18:5, pages 1543-1558.
Crossref
Crossref
Shrinivas Rathod, Jonathan Livergant, Jonathan Klein, Ian Witterick & Jolie Ringash. (2015) A systematic review of quality of life in head and neck cancer treated with surgery with or without adjuvant treatment. Oral Oncology 51:10, pages 888-900.
Crossref
Crossref
Michael D. Brundage, Katherine C. Smith, Emily A. Little, Elissa T. Bantug & Claire F. Snyder. (2015) Communicating patient-reported outcome scores using graphic formats: results from a mixed-methods evaluation. Quality of Life Research 24:10, pages 2457-2472.
Crossref
Crossref
Julie Rouette, Jane Blazeby, Madeleine King, Melanie Calvert, Yingwei Peng, Ralph M. Meyer, Jolie Ringash, Melanie Walker & Michael D. Brundage. (2014) Integrating health-related quality of life findings from randomized clinical trials into practice: an international study of oncologists’ perspectives. Quality of Life Research 24:6, pages 1317-1325.
Crossref
Crossref
Erin E. Kent, Anita Ambs, Sandra A. Mitchell, Steven B. Clauser, Ashley Wilder Smith & Ron D. Hays. (2015) Health-related quality of life in older adult survivors of selected cancers: Data from the SEER-MHOS linkage. Cancer 121:5, pages 758-765.
Crossref
Crossref
Melanie L Bell & Diane L Fairclough. (2013) Practical and statistical issues in missing data for longitudinal patient-reported outcomes. Statistical Methods in Medical Research 23:5, pages 440-459.
Crossref
Crossref
Jonathan Klein, Jonathan Livergant & Jolie Ringash. (2014) Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapy: A systematic review. Oral Oncology 50:4, pages 254-262.
Crossref
Crossref
Pamela L. WoltersStaci MartinVanessa L. MerkerKathy L. GardnerCynthia M. HingtgenJames H. TonsgardElizabeth K. SchorryAndrea Baldwin. (2013) Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials. Neurology 81:21_supplement_1.
Crossref
Crossref
A. Keith StewartSuzanne TrudelNizar J. BahlisDarrell WhiteWaleed SabryAndrew BelchTony ReimanJean RoyChaim ShustikMichael J. KovacsMorel RubingerGuy CantinKevin SongKirsty A. TompkinsDeb C. MarcellusMartha Q. LacyJonathan SussmanDonna ReeceMichael Brundage, Erica L. Harnett, Lois Shepherd, Judy-Anne W. Chapman & Ralph M. Meyer. (2013) A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial. Blood 121:9, pages 1517-1523.
Crossref
Crossref
John M. Salsman, Timothy Pearman & David Cella. 2013. Psychological Aspects of Cancer. Psychological Aspects of Cancer
255
278
.
Paul B. JacobsenLynne I. Wagner. (2012) A New Quality Standard: The Integration of Psychosocial Care Into Routine Cancer Care. Journal of Clinical Oncology 30:11, pages 1154-1159.
Crossref
Crossref
Michael D Brundage & Claire F Snyder. (2012) Patient-reported outcomes in clinical practice: using standards to break down barriers. Clinical Investigation 2:4, pages 343-346.
Crossref
Crossref
Michael Brundage, Brenda Bass, Ringash Jolie & Kimberley Foley. (2011) A knowledge translation challenge: clinical use of quality of life data from cancer clinical trials. Quality of Life Research 20:7, pages 979-985.
Crossref
Crossref